Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the infor...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 1998-10, Vol.102 (4), p.558-562 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 562 |
|---|---|
| container_issue | 4 |
| container_start_page | 558 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 102 |
| creator | Bousquet, Jean Lockey, Richard Malling, Hans-Jorgen |
| description | The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper “Allergen immunotherapy: Therapeutic vaccines for allergic diseases.”The historical term allergen
extract was changed to allergen
vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research. (J Allergy Clin Immunol 1998;102:558-62.) |
| doi_str_mv | 10.1016/S0091-6749(98)70271-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70023426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674998702714</els_id><sourcerecordid>70023426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-4112a4f7d860e8f14b8ab024ed5ba23d9b465cf380425112c04c6393268ae69e3</originalsourceid><addsrcrecordid>eNqFkMtOxCAUhonR6Hh5BJMujNFFFSil4MZMJt6SSWahxiWh9FQxbanQTuLby1wyW1fAOd8Phw-hc4JvCCb89hVjSVJeMHklxXWBaUFStocmBMsi5YLm-2iyQ47QcQjfOJ4zIQ_RoRSYZpxO0Me0acB_QpfYth07N3yB1_3vXfK23sA4WJMstTG2g5DUzid6HYjVygbQIVanycfzIuldsIN1XdLHmD9FB7VuApxt1xP0_vjwNntO54unl9l0npocF0PKCKGa1UUlOAZRE1YKXWLKoMpLTbNKloznps4EZjSPrMHM8ExmlAsNXEJ2gi439_be_YwQBtXaYKBpdAduDKrA8aOM8gjmG9B4F4KHWvXettr_KoLVSqhaC1UrW0oKtRaqWMydbx8YyxaqXWprMPYvtn0djG5qrztjww6jce68yCJ2v8Egylha8CoYC52Bynowg6qc_WeQP0Y_kbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70023426</pqid></control><display><type>article</type><title>Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Bousquet, Jean ; Lockey, Richard ; Malling, Hans-Jorgen</creator><creatorcontrib>Bousquet, Jean ; Lockey, Richard ; Malling, Hans-Jorgen ; the WHO panel members</creatorcontrib><description>The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper “Allergen immunotherapy: Therapeutic vaccines for allergic diseases.”The historical term allergen
extract was changed to allergen
vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research. (J Allergy Clin Immunol 1998;102:558-62.)</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/S0091-6749(98)70271-4</identifier><identifier>PMID: 9802362</identifier><identifier>CODEN: JACIBY</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Allergens - therapeutic use ; Biological and medical sciences ; Desensitization, Immunologic - standards ; Humans ; Hypersensitivity - therapy ; Immunopathology ; Immunotherapy (general aspects) ; Injections, Subcutaneous ; Medical sciences ; Vaccines - standards ; Vaccines - therapeutic use ; World Health Organization</subject><ispartof>Journal of allergy and clinical immunology, 1998-10, Vol.102 (4), p.558-562</ispartof><rights>1998 Mosby, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-4112a4f7d860e8f14b8ab024ed5ba23d9b465cf380425112c04c6393268ae69e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674998702714$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2425573$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9802362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bousquet, Jean</creatorcontrib><creatorcontrib>Lockey, Richard</creatorcontrib><creatorcontrib>Malling, Hans-Jorgen</creatorcontrib><creatorcontrib>the WHO panel members</creatorcontrib><title>Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper “Allergen immunotherapy: Therapeutic vaccines for allergic diseases.”The historical term allergen
extract was changed to allergen
vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research. (J Allergy Clin Immunol 1998;102:558-62.)</description><subject>Allergens - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Desensitization, Immunologic - standards</subject><subject>Humans</subject><subject>Hypersensitivity - therapy</subject><subject>Immunopathology</subject><subject>Immunotherapy (general aspects)</subject><subject>Injections, Subcutaneous</subject><subject>Medical sciences</subject><subject>Vaccines - standards</subject><subject>Vaccines - therapeutic use</subject><subject>World Health Organization</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOxCAUhonR6Hh5BJMujNFFFSil4MZMJt6SSWahxiWh9FQxbanQTuLby1wyW1fAOd8Phw-hc4JvCCb89hVjSVJeMHklxXWBaUFStocmBMsi5YLm-2iyQ47QcQjfOJ4zIQ_RoRSYZpxO0Me0acB_QpfYth07N3yB1_3vXfK23sA4WJMstTG2g5DUzid6HYjVygbQIVanycfzIuldsIN1XdLHmD9FB7VuApxt1xP0_vjwNntO54unl9l0npocF0PKCKGa1UUlOAZRE1YKXWLKoMpLTbNKloznps4EZjSPrMHM8ExmlAsNXEJ2gi439_be_YwQBtXaYKBpdAduDKrA8aOM8gjmG9B4F4KHWvXettr_KoLVSqhaC1UrW0oKtRaqWMydbx8YyxaqXWprMPYvtn0djG5qrztjww6jce68yCJ2v8Egylha8CoYC52Bynowg6qc_WeQP0Y_kbg</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Bousquet, Jean</creator><creator>Lockey, Richard</creator><creator>Malling, Hans-Jorgen</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper</title><author>Bousquet, Jean ; Lockey, Richard ; Malling, Hans-Jorgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-4112a4f7d860e8f14b8ab024ed5ba23d9b465cf380425112c04c6393268ae69e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Allergens - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Desensitization, Immunologic - standards</topic><topic>Humans</topic><topic>Hypersensitivity - therapy</topic><topic>Immunopathology</topic><topic>Immunotherapy (general aspects)</topic><topic>Injections, Subcutaneous</topic><topic>Medical sciences</topic><topic>Vaccines - standards</topic><topic>Vaccines - therapeutic use</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bousquet, Jean</creatorcontrib><creatorcontrib>Lockey, Richard</creatorcontrib><creatorcontrib>Malling, Hans-Jorgen</creatorcontrib><creatorcontrib>the WHO panel members</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bousquet, Jean</au><au>Lockey, Richard</au><au>Malling, Hans-Jorgen</au><aucorp>the WHO panel members</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>102</volume><issue>4</issue><spage>558</spage><epage>562</epage><pages>558-562</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><coden>JACIBY</coden><abstract>The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper “Allergen immunotherapy: Therapeutic vaccines for allergic diseases.”The historical term allergen
extract was changed to allergen
vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research. (J Allergy Clin Immunol 1998;102:558-62.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>9802362</pmid><doi>10.1016/S0091-6749(98)70271-4</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 1998-10, Vol.102 (4), p.558-562 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70023426 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Allergens - therapeutic use Biological and medical sciences Desensitization, Immunologic - standards Humans Hypersensitivity - therapy Immunopathology Immunotherapy (general aspects) Injections, Subcutaneous Medical sciences Vaccines - standards Vaccines - therapeutic use World Health Organization |
| title | Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A51%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allergen%20immunotherapy:%20Therapeutic%20vaccines%20for%20allergic%20diseases%20A%20WHO%20position%20paper&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Bousquet,%20Jean&rft.aucorp=the%20WHO%20panel%20members&rft.date=1998-10-01&rft.volume=102&rft.issue=4&rft.spage=558&rft.epage=562&rft.pages=558-562&rft.issn=0091-6749&rft.eissn=1097-6825&rft.coden=JACIBY&rft_id=info:doi/10.1016/S0091-6749(98)70271-4&rft_dat=%3Cproquest_cross%3E70023426%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70023426&rft_id=info:pmid/9802362&rft_els_id=S0091674998702714&rfr_iscdi=true |